Recombinant Human Anti-VEGF Antibody (Fab-12)

CAT#: PABX-185

Anti-VEGF antibody is a Chimeric antibody (mouse/human) of IgG1 κ class that binds to an VEGF.

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Human
  • Type
  • IgG
  • Specificity
  • Tested positive against native Human VEGF
  • Species Reactivity
  • Human
  • Clone
  • Fab-12
  • Applications
  • ELISA Assay-Dependent
    FuncS Assay-Dependent
    Block Assay-Dependent

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The antibody Fab-12 has been reported in applications of ELISA, FuncS, Block. It's recommended that the optimal antibody concentration, dilution, incubition time etc. are best to be carefully titrated in specific assays.

Target

  • Alternative Names
  • VEGF; Vascular endothelial growth factor; EPI0030; BD0801; Sevacizumab
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for PABX-185. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Great for VEGF-related experiments
The Recombinant Human Anti-VEGF Antibody (Fab-12) has significantly improved the accuracy of our angiogenesis assays. Its high affinity and specificity make it indispensable for our VEGF-related experiments. Highly recommended!
Breast cancer biomarkers at key points during disease progression
Helpful for studies on diabetic retinopathy
We are using this antibody for in vitro studies on diabetic retinopathy. The specificity and inhibition of the VEGF pathways we've observed have been highly insightful. This antibody is fundamental to our project
Breast cancer biomarkers at key points during disease progression
High affinity
The Recombinant Human Anti-VEGF Antibody (Fab-12) stands out for its high affinity, versatility in applications, and robust performance in both in vitro and in vivo models. It offers superior specificity and sensitivity compared to many commercially available VEGF antibodies.

Q&As

  1. What is the action mechanism of the Recombinant Human Anti-VEGF Antibody (Fab-12)?

    A: The mechanism involves specific binding to VEGF, which prevents VEGF from interacting with its receptors (VEGFR-1 and VEGFR-2) on the cell surface. This inhibition disrupts the downstream signaling involved in angiogenesis, thereby impeding new blood vessel formation.

  2. Can the Recombinant Human Anti-VEGF Antibody (Fab-12) be used in vivo studies?

    A: Yes, the Recombinant Human Anti-VEGF Antibody (Fab-12) has been tested and validated for in vivo studies. Its stability and efficacy in animal models have shown promising results in reducing angiogenesis-related disorders, such as tumor growth and diabetic retinopathy.

  3. What is the recommended concentration for using the Recombinant Human Anti-VEGF Antibody (Fab-12) in ELISA?

    A: For ELISA applications, a starting concentration of 1-2 µg/mL of the Recombinant Human Anti-VEGF Antibody (Fab-12) is recommended. This concentration can be optimized based on the specific requirements and sensitivity of the assay.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Related Diseases

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Clone Fab-12"

See other products for "VEGF"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
Gly-096LC Recombinant Anti-Human VEGF Antibody (Fc glycosylation) ELISA Humanized antibody
Gly-143LC Recombinant Anti-Human VEGF Antibody (Fc glycosylation) ELISA Humanized antibody
CAT Product Name Application Type
Gly-179LC Recombinant Anti-Human VEGF Antibody (Non-glycosylated) ELISA Human antibody
CAT Product Name Application Type
MOR-4485 Rabbit Anti-VEGF Recombinant Antibody (clone SI581DS) ELISA Rabbit IgG
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare